Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Dorota Sands"'
Autor:
Justyna Milczewska, Ewa Mierzejewska, Katarzyna Walicka-Serzysko, Katarzyna Zacharczuk, Tomasz Wołkowicz, Dorota Sands, Monika Kwiatkowska
Publikováno v:
Pediatric Pulmonology. 55:161-168
Introduction Pseudomonas aeruginosa cross-infections are related to increased morbidity and mortality in cystic fibrosis (CF). Objectives The aim of the study was to evaluate the incidence of cross-infections with P. aeruginosa in children with CF. M
Autor:
Ivanka Galeva, Zhanna Jumadilova, Monika Ciesielska, Amparo Solé, Alexandra L. Quittner, Predrag Minic, Marco Cipolli, Isabelle Fajac, John P. Clancy, Diana Bilton, Dorota Sands, Tacjana Pressler, Michael W. Konstan
Publikováno v:
J Cyst Fibros
Background . In CLEAR-108—a phase 3, randomised, open-label study—once-daily amikacin liposome inhalation suspension (ALIS) was noninferior to twice-daily tobramycin inhalation solution (TIS) in improving lung function in patients with cystic fib
Autor:
Karolina Anna, Mielko, Sławomir Jan, Jabłoński, Wojciech, Wojtowicz, Justyna, Milczewska, Dorota, Sands, Marcin, Łukaszewicz, Piotr, Młynarz
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 188
The study aimed to assess whether Pseudomonas aeruginosa strains from different sources can be distinguished by the metabolomic fingerprint and to check whether antibiotic susceptibility distinctions are available through metabolomic analysis.
Autor:
Łukasz Pruss, Justyna Milczewska, Dorota Sands, Piotr Młynarz, Karolina Anna Mielko, Sławomir Jabłoński, Marcin Łukaszewicz
Publikováno v:
International Journal of Molecular Sciences
Volume 22
Issue 19
International Journal of Molecular Sciences, Vol 22, Iss 10820, p 10820 (2021)
Volume 22
Issue 19
International Journal of Molecular Sciences, Vol 22, Iss 10820, p 10820 (2021)
Pseudomonas aeruginosa is a common human pathogen belonging to the ESKAPE group. The multidrug resistance of bacteria is a considerable problem in treating patients and may lead to increased morbidity and mortality rate. The natural resistance in the
Autor:
Diana Bilton, Tacjana Pressler, Isabelle Fajac, John Paul Clancy, Dorota Sands, Predrag Minic, Marco Cipolli, Ivanka Galeva, Amparo Solé, Alexandra L. Quittner, Keith Liu, John P. McGinnis, Gina Eagle, Renu Gupta, Michael W. Konstan, Sabine Renner, Christiane Knoop, Anne Malfroot, Lieven Dupont, Kristine Desager, Frans De Baets, Miroslava Bosheva, Vania Nedkova, Ivan Galabov, Andreas Freitag, Nancy Morrison, Pearce Wilcox, Tanja Pressler, Yves Martinet, Raphael Chiron, Stephan Dominique, Philippe Reix, Anne Prevotat, Isabelle Sermet, Isabelle Durieu, Rainald Fischer, Rudolf Huber, Doris Staab, Uwe Mellies, Wolfgang Sextro, Tobias Welte, Heinrike Wilkens, Urte Sommerwerk, Burkhard Bewig, Ilias Inglezos, Stavros-Eleftherios Doudounakis, Olga Bede, Ferenc Gönczi, Rita Újhelyi, Edward McKone, Paul McNally, Vincenzina Lucidi, Mario La Rosa, Laura Minicucci, Rita Padoan, Giovanna Pisi, Rolando Gagliardini, Carla Colombo, Inez Bronsveld, Ewa Sapiejka, Henryk Mazurek, Grażyna Górnicka, Iwona Stelmach, Halina Batura-Gabryel, Marta Rachel, Jaroslava Orosova, Branko Takac, Anna Feketova, Carmen Martinez, Gloria Garcia Hernandez, Jose Ramon Villa-Asensi, Silvia Gartner, Amparo Sole, Anders Lindblad, Martin Ledson, Joanna Whitehouse, Alan Smyth, Ian Ketchell, Timothy Lee, Gordon MacGregor
Publikováno v:
J Cyst Fibros
Background Shortcomings of inhaled antibiotic treatments for Pseudomonas aeruginosa infection in patients with cystic fibrosis (CF) include poor drug penetration, inactivation by sputum, poor efficiency due to protective biofilm, and short residence
Publikováno v:
Pediatric pulmonology. 54(6)
The impact of infections caused by bacteria, especially Gram-negative, on the progression of lung disease in cystic fibrosis is well established. Decline in pulmonary function commence already at early age. In this group of patients, the lung clearan
Publikováno v:
Developmental period medicine. 19(1)
1. Evaluation of health-related quality of life (HRQOL) in adolescents with cystic fibrosis (CF). 2. Evaluation of HRQOL in children with CF from the parents' perspective. 3. Evaluation of the relationship between HRQOL and both medical and psychosoc
Publikováno v:
Pediatric endocrinology, diabetes, and metabolism. 18(4)
Somatic development and respiratory function are the most important prognostic factors for the course of the disease and the expected lifespan of patients suffering from cystic fibrosis (cF). Aim of the study was to evaluate nutritional status and pu
Autor:
H. Mazurek, Eszter Csiszer, Kàlmàn Gyurkovics, Maria Trawińska Bartnicka, A. Chuchalin, Guido Varoli, N. I. Kapranov, Pier Alessandro Monici Preti, Dorota Sands
Publikováno v:
Paediatric drugs. 9
Chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis (CF) causes progressive deterioration in lung function. The purpose of this trial was to assess the efficacy and tolerability of a tobramycin highly concentrated solution
Publikováno v:
Journal of Cystic Fibrosis. (6):653-660
Background Tobramycin inhalation is an accepted treatment of chronic pseudomonal infection in cystic fibrosis (CF) patients. Twice daily inhalation is efficacious, but time-consuming. Methods In this randomized, open-label, multicentre, two-period, c